Two-Year Autism Risk Screening and 3-Year Developmental Outcomes in Very Preterm Infants
JAMA Pediatrics · 2024
DOI: 10.1001/jamapediatrics.2023.5727 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Pediatrics, 2024. Verfasst von Coral L Shuster und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Brown Center for the Study of Children at Risk, Women and Infants Hospital, Providence, Rhode Island. Hauptthemen laut MEDLINE: Autistic Disorder, Infant, Premature, Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS.
Themen: Neonatologie
Abstract (Originalsprache)
Importance Use of the Modified Checklist for Autism in Toddlers, Revised With Follow-Up, a 2-stage parent-report autism risk screening tool, has been questioned due to reports of poor sensitivity and specificity. How this measure captures developmental delays for very preterm infants may provide support for continued use in pediatric care settings.
Objective
To determine whether autism risk screening with the 2-stage parent-report autism risk screening tool at age 2 years is associated with behavioral and developmental outcomes at age 3 in very preterm infants. Design, Setting, and Participants Neonatal Neurobehavior and Outcomes for Very Preterm Infants was a longitudinal, multisite cohort study. Enrollment occurred April 2014 to June 2016, and analyses were conducted from November 2022 to May 2023. Data were collected across 9 university-affiliated neonatal intensive care units (NICUs). Inclusion criteria were infants born less than 30 weeks’ gestational age, a parent who could read and speak English and/or Spanish, and residence within 3 hours of the NICU and follow-up clinic. Exposures Prematurity and use of the 2-stage parent-report autism risk screening tool at age 2 years. Main Outcomes and Measures Outcomes include cognitive, language, motor composites on Bayley Scales for Infant and Toddler Development, third edition (Bayley-III) and internalizing, externalizing, total problems, and pervasive developmental disorder (PDD) subscale on the Child Behavior Checklist (CBCL) at age 3 years. Generalized estimating equations tested associations between the 2-stage parent-report autism risk screening tool and outcomes, adjusting for covariates.
Results
A total of 467 children (mean [SD] gestational age, 27.1 [1.8] weeks; 243 male [52%]) were screened with the 2-stage parent-report autism risk screening tool at age 2 years, and outcome data at age 3 years were included in analyses. Mean (SD) maternal age at birth was 29 (6) years. A total of 51 children (10.9%) screened positive on the 2-stage parent-report autism risk screening tool at age 2 years. Children with positive screening results were more likely to have Bayley-III composites of 84 or less on cognitive (adjusted odds ratio [aOR], 4.03; 95% CI, 1.65-9.81), language (aOR, 5.38; 95% CI, 2.43-11.93), and motor (aOR, 4.74; 95% CI, 2.19-10.25) composites and more likely to have CBCL scores of 64 or higher on internalizing (aOR, 4.83; 95% CI, 1.88-12.44), externalizing (aOR, 2.69; 95% CI, 1.09-6.61), and PDD (aOR, 3.77; 95% CI, 1.72-8.28) scales. Conclusions and Relevance Results suggest that the 2-stage parent-report autism risk screening tool administered at age 2 years was a meaningful screen for developmental delays in very preterm infants, with serious delays detected at age 3 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Brown Center for the Study of Children at Risk, Women and Infants Hospital, Providence, Rhode Island.
- Thompson Center for Autism and Neurodevelopment, University of Missouri, Columbia.
- Brown Alpert Medical School, Providence, Rhode Island.
- UNC School of Medicine, Chapel Hill, North Carolina.
- Children's Mercy Hospital, Kansas City, Missouri.
- Wake Forest School of Medicine, Winston-Salem, North Carolina.
Förderung
- NICHD NIH HHS
- NIH HHS
Zitieren
APA
Shuster, C. L., Sheinkopf, S. J., McGowan, E. C., Hofheimer, J. A., O'Shea, T. M., Carter, B. S., Helderman, J. B., Check, J., Neal, C. R., Pastyrnak, S. L., Smith, L. M., Loncar, C., Dansereau, L. M., DellaGrotta, S. A., Marsit, C. J., & Lester, B. M. (2024). Two-Year Autism Risk Screening and 3-Year Developmental Outcomes in Very Preterm Infants. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2023.5727
Vancouver
Shuster CL, Sheinkopf SJ, McGowan EC, Hofheimer JA, O'Shea TM, Carter BS, et al. Two-Year Autism Risk Screening and 3-Year Developmental Outcomes in Very Preterm Infants. JAMA Pediatrics. 2024. doi:10.1001/jamapediatrics.2023.5727
BibTeX
@article{Shuster2024,
author = {Shuster, Coral L and Sheinkopf, Stephen J and McGowan, Elisabeth C and Hofheimer, Julie A and O'Shea, T Michael and Carter, Brian S and Helderman, Jennifer B and Check, Jennifer and Neal, Charles R and Pastyrnak, Steven L and Smith, Lynne M and Loncar, Cynthia and Dansereau, Lynne M and DellaGrotta, Sheri A and Marsit, Carmen J and Lester, Barry M},
title = {Two-Year Autism Risk Screening and 3-Year Developmental Outcomes in Very Preterm Infants},
journal = {JAMA Pediatrics},
year = {2024},
doi = {10.1001/jamapediatrics.2023.5727}
}
EUVIMED